Views
No views yet

Fastino-Nemotron-3.5-Lightning-Healthcare is a 30B-parameter, 3B-active mixture-of-experts model specialized for healthcare and biomedical applications. The repository contains a ready-to-run merged checkpoint: the NVIDIA Nemotron 3.5 Lightning checkpoint released July 29, 2026 plus Fastino's winning combined-healthcare E17b adapter. Users do not need to obtain or attach a separate LoRA.pip install "vllm==0.23.0"1from vllm import LLM, SamplingParams
2
3model_id = "fastino/Fastino-Nemotron-3.5-Lightning-Healthcare"
4
5llm = LLM(
6 model=model_id,
7 trust_remote_code=True,
8 dtype="bfloat16",
9 max_model_len=4096,
10)
11
12clinical_note = """65-year-old male with history of hypertension, type 2
13diabetes, and CKD stage 3 presents with 2 weeks of progressive dyspnea on
14exertion and orthopnea. Exam: bibasilar crackles, 3+ pitting edema to knees,
15BP 152/94. Meds: lisinopril 20 mg daily, furosemide 40 mg daily. CXR:
16cardiomegaly with pulmonary congestion. Assessment: acute decompensated
17heart failure."""
18
19messages = [
20 {
21 "role": "system",
22 "content": "You are a clinical documentation assistant. Summarize notes accurately and concisely. Do not add information that is not in the note.",
23 },
24 {
25 "role": "user",
26 "content": f"Summarize the following clinical note in 3-5 bullet points:\n\n{clinical_note}",
27 },
28]
29
30outputs = llm.chat(
31 messages,
32 SamplingParams(temperature=0.0, max_tokens=512),
33)
34print(outputs[0].outputs[0].text)1.5e-4, batch size 32, and sequence packing disabled. Evaluation, development, and blind rows and their labels were excluded from training.| Benchmark | Evaluation scope | July 29 base | Fastino-Healthcare | Change |
|---|---|---|---|---|
| HealthBench Pro | blind, n=180 | 26.83% | 32.64% | +5.80 pp |
| HealthAdminBench | blind | 25.67% | 29.95% | +4.28 pp |
| MedAgent public v1/v2, Overall SR | blind, n=150 | 36.00% | 40.00% | +4.00 pp |
| HealthBench Core | blind, n=700 | 49.67% | 56.21% | +6.54 pp |
| PubMedQA | matched, n=500 | 59.00% | 65.00% | +6.00 pp |
| MedCalc | matched, n=275 | 49.09% | 54.18% | +5.09 pp |
| MEDEC, flag accuracy | matched, n=574 | 53.66% | 64.98% | +11.32 pp |
| MEDEC, sentence accuracy | matched, n=574 | 48.08% | 62.89% | +14.81 pp |
| MedMentions ST21pv | matched, n=878 | 19.74% | 40.30% | +20.55 pp |
| BC5CDR | matched, n=500 | 47.92% | 72.51% | +24.59 pp |
| Benchmark | Evaluation scope | July 29 base | Fastino-Healthcare | Change |
|---|---|---|---|---|
| EkaCare | transfer, n=1,066 | 12.95% | 32.83% | +19.88 pp |
| BC5CDR to BioRED | transfer, n=66 | 25.92% | 41.77% | +15.85 pp |
1@misc{atreja2026pioneeragentcontinualimprovement,
2 title={Pioneer Agent: Continual Improvement of Small Language Models in Production},
3 author={Dhruv Atreja and Julia White and Nikhil Nayak and Kelton Zhang and Henrijs Princis and George Hurn-Maloney and Ash Lewis and Urchade Zaratiana},
4 year={2026},
5 eprint={2604.09791},
6 archivePrefix={arXiv},
7 primaryClass={cs.AI},
8 url={https://arxiv.org/abs/2604.09791},
9}